國家衛生研究院 NHRI:Item 3990099045/16150
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 855517      線上人數 : 1173
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版
    國家衛生研究院 NHRI > 癌症研究所 > 張光裕 > 圖書 >  Item 3990099045/16150


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/16150


    題名: Hypoxia in drug resistance and radioresistance
    作者: Chang, KY;Lin, IL;Cheung, CHA
    貢獻者: National Institute of Cancer Research
    摘要: Tumors mostly experience hypoxia or hypoxic stress as they progress, especially for tumor cells that are located far from the functional blood vessels. Pathologically. tumor hypoxia is known to play an important role in tumor progression, and it also contributes to the development of chemoresistance and radioresistance. Among different intracellular signaling pathways, the hypoxia-inducible factor-1 (HIF-1) signaling pathway is the most studied and known for its importance in regulating the survival of cells, including cancer cells, under hypoxic conditions. In the following sections, the molecular biology of hypoxia and the HIF-1 signaling pathway will be briefly reintroduced. Importantly, the role of hypoxia in tumor chemoresistance and radioresistance will be discussed in detail.
    日期: 2023-04-14
    關聯: Hypoxia in Cancer: Significance and Impact on Cancer Therapy. 2023 Apr 14:433-447.
    Link to: http://dx.doi.org/10.1007/978-981-99-0313-9_19
    Cited Times(Scopus): https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85202273655
    顯示於類別:[張光裕] 圖書

    文件中的檔案:

    沒有與此文件相關的檔案.



    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋